Oberweis Asset Management »

Eli Lilly & Co. shares owned by Oberweis Asset Management

Quarter-by-quarter ownership of Eli Lilly & Co. (LLY) shares owned by Oberweis Asset Management from 13F filings

Historical chart of Oberweis Asset Management investment in Eli Lilly & Co.

Tip: Access up to 7 years of quarterly data

All positions including Eli Lilly & Co. held by Oberweis Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eli Lilly & Co. by Oberweis Asset Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $286k 609 469.04
2023-03-31 $209k 609 343.36
2022-12-31 $234k 639 365.65
2022-09-30 $216k 668 323.35
2022-06-30 $217k 668 324.85

More positions owned by Oberweis Asset Management

Credo Technology Group Holding (CRDO)
Lumentum Hldgs (LITE)
Rambus (RMBS)
Ambarella (AMBA)
Sharkninja (SN)
Applied Optoelectronics (AAOI)
Encompass Health Corp (EHC)
Frontdoor (FTDR)
Adma Biologics (ADMA)
American Superconductor (AMSC)
Sportradar Group Ag Class A Ord (SRAD)
NOVA MEASURING Instruments L (NVMI)
Itron (ITRI)
SkyWest (SKYW)
Sitime Corp (SITM)

View all positions for Oberweis Asset Management

Top funds holding Eli Lilly & Co.

Lilly Endowment
Vanguard Group
BlackRock
Pnc Financial Services
State Street Corporation
Capital Research Global Investors
FMR
Geode Capital Management
Capital World Investors
Wellington Management Company
State Farm Mutual Automobile Insurance Company
PRIMECAP Management Company
Jpmorgan Chase & Co
Capital Research and Management Company - Division 3
Northern Trust

View all funds holding Eli Lilly & Co.